The title compound ( Fig. 1 ) increases regional cerebral blood flow.l Transparent yellow prisms of BY-1949, grown from a methanol solution2, were subjected to the crystal structure analysis. Experimental conditions: crystal size 0.50X0.45X0.15 mm, Cu Ka radiation (graphite-monochromated), 0-20 scan with variable scan speed 1.03 -4.12° / min(0), scan width (0.50+0.14 tan O)°, range of indices -15shs 15, Oslo 13, OS l~ 12 (20< 150°). Lattice constants were determined based on twenty-five 20 values (34<20<67°). No significant changes in the intensities of three standard reflections were observed during data collection. A total of 2691 unique reflections were collected, of which 2495 observed reflections with I>2a(I) were used for refinement of the structure.
The structure was solved by direct methods with MULTAN 11/82, and refined by a full-matrix least squares method. All hydrogen atoms were found on DFourier maps. Non-H atoms were refined with anisotropic thermal parameters and H atoms with the isotropic ones (fixed at B=5.0 A2). The quantity w(I Fo I -I F~ I )2 was minimized; w=1.0 for I F01<78.50, w=(78. The crystal and experimental data are given in Table 1 , and the final atomic parameters are in Table 2 . The molecular structure is shown in Fig. 2 , together with an atom-numbering scheme. The bond distances and angles are listed in Table 3 . The oxazepine ring of BY- 
